Few biotechnology innovations make it through the Valley of Death to markets. Based on our experience with academia, technology transfer offices, and industry, we provide insights into differences in operating levels, how to best traverse the Valley of Death, and ways to foster more innovation towards market implementation.
No takes yet. Share an insight, caveat, or question.
Kampers et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: